 Inflammation<symptom> plays an important role in the development of atherosclerosis and its complications. Because the folate receptor β ( FR-β) is selectively expressed on macrophages , an FR targeted imaging agent could be useful for assessment of atherosclerotic inflammation<symptom>. We investigated aluminum fluoride-18-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid conjugated folate (